Company Name or Ticker Symbol
Search for other Categories
Akers Biosciences, Inc.  (AKER)
Other Ticker:  
    Sector  Services    Industry Broadcasting Media & Cable TV


Redemption of Losses due Decrease in Demand

decrease font size NEWS BETA Increase font size

Akers Biosciences, Inc announced first quarter 2017 operating loss of $-1.362153 millions

Lower demand led to lower revenues and higher losses, in the first quarter 2017 company decreased loss to $-0.19 per share, while Sales fell by -9.59 % to $1 millions, year on year.

In the previous quarter company realized Sales of $1 millions and bottom line of $-0.20 per share.

In the first quarter 2017 Akers Biosciences, Inc reported net loss of $-1 million, instead of deficit of $-2 millions in the same quarter a year ago.
Other AKER's Earnings Reports

Akers Biosciences reported forth quarter 2016 earnings

Akers Biosciences reported third quarter 2016 earnings

Akers Biosciences reported second quarter 2016 earnings

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com